Adacel

Ingredient

noninfectious tetanus, diphtheria, and pertussis proteins, aluminum
phosphate, 2-phenoxyethanol, and residual amounts of formaldehyde and glutaraldehyde.

Content

Indication

active booster immunization against
tetanus, diphtheria and pertussis. Adacel is approved for use in persons 10
through 64 years of age.

Aggrastat Inj.

Ingredient

Tirofiban Hydrochloride Hydrate　

Content

14.05mg/50ml (12.5mg/50ml as tirofiban)

Indication

Co-administration with heparin in the patients who are:
– target patients in the treatment of acute coronary syndrome (ACS)
– patients with percutaneous transluminal coronary angioplasty (PTCA) or atherectomy

It has been shown to reduce the incidence of death, myocardial infarction, or combined endpoints of refractory ischemia/recardiac procedures.

Allegra Tab. 180mg

Ingredient

Fexofenadine Hydrochloride

Content

180mg

Indication

Relief of symptoms associated with allergic skin disease (chronic idiopathic urticaria).

Allegra Tab. 30mg

Ingredient

Fexofenadine Hydrochloride

Content

30mg

Indication

Relief of symptoms associated with seasonal allergic rhinitis and allergic skin diseases (chronic idiopathic urticaria)

Amaryl M Tab.

Ingredient

Glimepiride/Metformin Hydrochloride

Content

1/250mg, 1/500mg, 2/500mg

Indication

This drug is administered as an adjunct to diet and exercise to improve the glucose control of patients with type 2 diabetes who are adequate to combination therapy of glimepiride and metformin.

Amaryl Mex SR Tab.

Ingredient

Glimepiride/Metformin Hydrochloride

Content

2mg/500mg

Indication

This drug is administered as an adjunct to diet and exercise to improve the glucose control of patients with type 2 diabetes who are adequate to combination therapy of glimepiride and metformin.

Amaryl Tab.

Ingredient

Glimepiride

Content

1mg, 2mg, 4mg

Indication

This drug is administered as an adjunct to diet and exercise to improve the glucose control of patients with type 2 diabetes.
– Monotherapy
– Combination therapy

Aprovasc®Tablet 150/10mg

Ingredient

Amlodipine Besylate 14mg (Amlodipine 10mg)
Irbesartan 150mg

Content

Pink oval film-coated tablet

Indication

Essential hypertension not adequately controlled with Irbesartan monotherapy

Aprovasc®Tablet 150/5mg

Ingredient

Amlodipine Besylate 7mg (Amlodipine 5mg)
Irbesartan 150mg

Content

White oval film-coated tablet

Indication

Essential hypertension not adequately controlled with Irbesartan monotherapy

Aprovasc®Tablet 300/5mg

Ingredient

Amlodipine Besylate 7mg (Amlodipine 5mg)
Irbesartan 300mg

Content

Yellow oval film-coated tablet

Indication

Essential hypertension not adequately controlled with Irbesartan monotherapy